DOI:

False lumen stenting: uncommon stent occlusion demonstrated by intravascular ultrasound

Shinichi Furuichi*, MD; Davide Tavano, MD; Altin Palloshi, MD; Antonio Colombo, MD

A 53-year-old man with hypertension and hyperlipidaemia was referred to our hospital for a third attempt to recanalise an occlusive in-stent restenosis (ISR) in the circumflex artery (LCX). In 2003, the patient had inferolateral myocardial infarction with a triple-vessel disease. Coronary bypass grafting was performed. In March 2006, stress scintigraphy for screening showed lateral ischaemia. Coronary angiography revealed an occlusion of the right internal mammary artery to a posterolateral branch. In another centre, coronary intervention was performed for subtotal occlusion in the LCX (Figure 1A). During the procedure a guidewire entered a false lumen (Figure 1B) and finally two bare metal stents were implanted with distal TIMI 2 flow (Figure 1C). Four months later, an occlusive restenosis was found. Two previous attempts failed to reopen the vessel.

Figure 1. Initial coronary intervention for a subtotal occlusion in the LCX.

Control angiography showed occlusive ISR (Figure 2A). After crossing a guidewire and predilatation (Figure 2B), IVUS demonstrated that the distal stent was completely positioned in the false lumen and the guidewire re-entered the true lumen 18 mm distal to the stent distal edge. (Figure 2a-e).

Figure 2. Control angiography with IVUS revealing occlusive in-stent restenosis.

The true lumen (*) was observed out of stent struts. Angiography with IVUS transducer positioned at the re-entry point (Figure 3A, arrow) was performed for a guide to optimal stenting and three sirolimus eluting stents (SES) were implanted with excellent angiographic result (Figure 3B). Post-intervention IVUS confirmed SES covered entire false lumen and connected the proximal true lumen with the distal one. The vessel was open at four months follow-up (Figure 3C).

Figure 3. Coronary angiography with implantation of 3 sirolimus-eluting stents.

Volume 4 Number 2
Aug 20, 2008
Volume 4 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
335.05

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved